Quantcast
Last updated on April 16, 2014 at 13:48 EDT

Latest Petra Rietschel Stories

2012-10-25 04:01:03

GlaxoSmithKline is experimenting with a new combination of cancer medications; Petra Rietschel, MD encourages such exploration. White Plains, New York (PRWEB) October 24, 2012 Bloomberg Businessweek reports that GlaxoSmithKline Plc has combined two medications designed to treat melanoma in an effort to slow the growth of the cancer. According to the article, a study has found that this combination has succeeded in limiting the progression of the disease more successfully than a single-drug...